StockData
Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc (KPRX) stock

KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.93−0.05 (-5.30%)

Close on Nov 17, 2026Market cap $4.11MP/E –Yield –

Kiora Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Kiora Pharmaceuticals's profit margin for the twelve months ending Mar 31, 2025 was -60257.3%. For fiscal 2024 it was 22.4%, against -56901.7% the year before. The highest annual figure on record is 22.4% in fiscal 2024.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 202422.4%+56924.1
FY2020Dec 31, 2020-56901.7%−56637.4
FY2019Dec 31, 2019-264.2%+390.0
FY2018Dec 31, 2018-654.2%+2589.3
FY2017Dec 31, 2017-3243.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2024Jun 30, 2024-11108.2%−10115.0
Q1 FY2024Mar 31, 202484.1%+1232.9
Q4 FY2020Dec 31, 2020-9831.6%−9614.5
Q1 FY2019Mar 31, 201932.4%+5575.4
Q3 FY2018Sep 30, 2018-993.3%+1250.2
Q2 FY2018Jun 30, 2018-1148.8%+433.4
Q1 FY2018Mar 31, 2018-217.1%–
Q3 FY2017Sep 30, 2017-5543.0%–
Q2 FY2017Jun 30, 2017-2243.5%–
Q1 FY2017Mar 31, 2017-1582.2%–

More Kiora Pharmaceuticals figures

See a number that looks wrong?